logo
Select company
Select metric
0%Inventory to Assets Ratio
VS
Market
48
Sector
44
Industry
23
History
-
$ 4.72Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information

Ticker

TSHA

Company Name

TAYSHA GENE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TAYSHA GENE THERAPIES INC - Inventory to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TSHA - Inv. to Assets Historical data
DateTotal AssetsInventoryInventory to Assets Ratio
6/30/2025$ 333.33M$ 00%
3/31/2025$ 138.36M$ 00%
12/31/2024$ 160.36M$ 00%
9/30/2024$ 180.22M$ 00%
6/30/2024$ 200.39M$ 00%
3/31/2024$ 153M$ 00%
12/31/2023$ 172.73M$ 00%
9/30/2023$ 195.77M$ 00%
6/30/2023$ 81.54M$ 00%
3/31/2023$ 101.6M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) Inv. to Assets stands at 0%.
  • Over the past 5 years, TAYSHA GENE THERAPIES INC's average Inv. to Assets has been 0%.
  • The median Inv. to Assets for TAYSHA GENE THERAPIES INC during this period was 0%
  • TAYSHA GENE THERAPIES INC reached its highest Inv. to Assets over the past 5 years at 0%.
  • The lowest Inv. to Assets recorded by TAYSHA GENE THERAPIES INC in the same timeframe 0%

TAYSHA GENE THERAPIES INC's Inv. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. to Assets Benchmarks
CompanyInv. to Assets
RLAY : RELAY THERAPEUTICS INC 0%PRAX : PRAXIS PRECISION MEDICINES INC 0%LENZ : LENZ THERAPEUTICS INC 0%DNTH : DIANTHUS THERAPEUTICS INC 0%IMNM : IMMUNOME INC 0%TNXP : TONIX PHARMACEUTICALS HOLDING CORP 3.19%PRME : PRIME MEDICINE INC 0%NUVB : NUVATION BIO INC 0.09%PGEN : PRECIGEN INC 0%ATAI : ATAI LIFE SCIENCES NV 0%

Definition of Inventory to Assets Ratio

[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for TAYSHA GENE THERAPIES INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 279.27M ]
(=) Inv. to Assets [ 0% ]

TSHA - Inventory to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

Inv. to Assets Benchmark Analysis

The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
filtered constituents4.46K
min0%
max98.39%
average6.08%
median0%
std11.11%